Anavex Life Sciences
AVXL
#7563
Rank
โ‚น35.31 B
Marketcap
โ‚น395.28
Share price
-1.12%
Change (1 day)
-38.58%
Change (1 year)

Anavex Life Sciences (AVXL) - Net assets

Net assets on the balance sheet as of June 2025 : โ‚น8.17 Billion

According to Anavex Life Sciences 's latest financial reports the company has โ‚น8.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Anavex Life Sciences - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$โ‚น10.08 B-14.56%
2023-09-30$โ‚น11.79 B1.73%
2022-09-30$โ‚น11.59 B3.56%
2021-09-30$โ‚น11.19 B457.86%
2020-09-30$โ‚น2.00 B39.5%
2019-09-30$โ‚น1.43 B-11.09%
2018-09-30$โ‚น1.61 B2.17%
2017-09-30$โ‚น1.58 B275.66%
2016-09-30$โ‚น0.42 B-49.76%
2015-09-30$โ‚น0.83 B6948.42%
2014-09-30$โ‚น11.9 M-107.73%
2013-09-30$-โ‚น0.16 Billion1.45%
2012-09-30$-โ‚น0.16 Billion170.94%
2011-09-30$-โ‚น56.09 Million-57.49%
2010-09-30$-โ‚น0.14 Billion-28.37%
2009-09-30$-โ‚น0.19 Billion72.54%
2008-09-30$-โ‚น0.11 Billion481.79%
2007-09-30$-โ‚น18.35 Million2483.12%
2006-09-30$-โ‚น0.72 Million-37.91%
2005-09-30$-โ‚น1.15 Million-197.21%
2004-09-30$โ‚น1.17 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น85.35 B 944.63%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น34.85 Billion-526.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น56.76 B 594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.58 Billion-107.02%๐Ÿ‡บ๐Ÿ‡ธ USA